Cargando…
Amyloid Beta Dynamics in Biological Fluids—Therapeutic Impact
Despite the significant impact of Alzheimer’s disease (AD) at individual and socioeconomic levels and the numerous research studies carried out on this topic over the last decades, the treatments available in daily clinical practice remain less than satisfactory. Among the accepted etiopathogenic hy...
Autores principales: | Schreiner, Thomas Gabriel, Popescu, Bogdan Ovidiu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8706225/ https://www.ncbi.nlm.nih.gov/pubmed/34945282 http://dx.doi.org/10.3390/jcm10245986 |
Ejemplares similares
-
The Roles of the Amyloid Beta Monomers in Physiological and Pathological Conditions
por: Schreiner, Thomas Gabriel, et al.
Publicado: (2023) -
The “Cerebrospinal Fluid Sink Therapeutic Strategy” in Alzheimer’s Disease—From Theory to Design of Applied Systems
por: Schreiner, Thomas Gabriel, et al.
Publicado: (2022) -
Impact of Caffeine on Alzheimer’s Disease Pathogenesis—Protective or Risk Factor?
por: Schreiner, Thomas Gabriel, et al.
Publicado: (2022) -
Nanoporous Membranes for the Filtration of Proteins from Biological Fluids: Biocompatibility Tests on Cell Cultures and Suggested Applications for the Treatment of Alzheimer’s Disease
por: Schreiner, Thomas Gabriel, et al.
Publicado: (2022) -
The Blood–Brain Barrier—A Key Player in Multiple Sclerosis Disease Mechanisms
por: Schreiner, Thomas Gabriel, et al.
Publicado: (2022)